Author

E. Mocholi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:host-pathogen & immune response· 1 Assay:organoid / primary culture· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Cutilli· 2 shared C. A. Lindemans· 2 shared M. Mokry· 2 shared P. J. Coffer· 2 shared S. A. Jansen· 2 shared A. Hanash· 1 shared B. Vastert· 1 shared C. C. de Koning· 1 shared

Activity by Year

2023-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Cutilli

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Glycolytic reprogramming shapes the epigenetic landscape of activated CD4+ T Cells in Juvenile Idiopathic Arthritis

E. Mocholi, T. Chalkiadakis, C. Gulersonmez, E. Stigter, B. Vastert, J. van Loosdregt, S. Prekovic, P. Coffer

This study shows that glycolytic reprogramming in JIA CD4+ T cells drives epigenetic changes linked to inflammation, with potential therapeutic implications.

bioRxiv · Feb 14, 2024 · PreprintImmunology

IFNγ induces epithelial reprogramming driving CXCL11-mediated T cell migration

A. Cutilli, S. A. Jansen, F. Paolucci, M. Mokry, E. Mocholi, C. A. Lindemans, P. J. Coffer

This study shows IFNγ reprograms intestinal epithelial organoids to secrete CXCL11, which enhances T cell migration without affecting T cell activation.

bioRxiv · Feb 3, 2024Immunology

Chemotherapy-induced intestinal injury promotes Galectin-9-driven modulation of T cell function

P. J. Coffer, C. A. Lindemans, A. Cutilli, S. A. Jansen, C. C. de Koning, M. van Hoesel, S. Nierkens, M. Mokry, E. E. Nieuwenhuis, E. Mocholi, A. Hanash

This study shows chemotherapy-induced intestinal damage promotes T cell activation and trafficking via galectin-9, linking epithelial injury to GVHD pathogenesis.

bioRxiv · Apr 30, 2023 · PreprintImmunology